Return to Today's science sparks archives

2017-01-03

Steve Gschmeissner/Science Photo Library

Steve Gschmeissner/Science Photo Library
  • Healey JH

  • Lancet Oncol. 2016 Dec;17(12):1633-1634.

2017-01-04

Fig 1. Geographic stratification for the British Columbia Telehealth Trial with example Block 1 configuration in Northern Health Region.

Fig 1. Geographic stratification for the British Columbia Telehealth Trial with example Block 1 configuration in Northern Health Region.
  • Cunanan KM, Carlin BP, Peterson KA

  • Clin Trials. 2016 Dec;13(6):641-650.

2017-01-05

Fig 1. Bethesda category III: atypical follicular lesion of undetermined significance.

Fig 1. Bethesda category III: atypical follicular lesion of undetermined significance.
  • Zhang M, Lin O

  • Arch Pathol Lab Med. 2016 Dec;140(12):1338-1344.

2017-01-06

Fig 1. Generation and validation of a stable cell line overexpressing ornithine decarboxylase (ODC).

Fig 1. Generation and validation of a stable cell line overexpressing ornithine decarboxylase (ODC).
  • Shukla-Dave A, Castillo-Martin M, Chen M, Lobo J, Gladoun N, Collazo-Lorduy A, Khan FM, Ponomarev V, Yi Z, Zhang W, Pandolfi PP

  • Am J Pathol. 2016 Dec;186(12):3131-3145.

2017-01-10

Fig 3. Direct repression of the elav 3′ UTR via the miRNA pathway and miR-279/996.

Fig 3. Direct repression of the elav 3′ UTR via the miRNA pathway and miR-279/996.
  • Sanfilippo P, Smibert P, Duan H, Lai EC

  • Development. 2016 Dec 1;143(23):4474-4485.

2017-01-11

Fig 10. Schematic of the one-step (A) and SPAAC-mediated two-step (B) approaches to the bioconjugation of antibodies using transglutaminase (TGase).

Fig 10. Schematic of the one-step (A) and SPAAC-mediated two-step (B) approaches to the bioconjugation of antibodies using transglutaminase (TGase).
  • Meyer JP, Adumeau P, Lewis JS, Zeglis BM.

  • Bioconjug Chem. 2016 Dec 21;27(12):2791-2807.

2017-01-12

Fig 4. CT post-contrast appearance of a G2 pNET.

Fig 4. CT post-contrast appearance of a G2 pNET.
  • Belousova E, Karmazanovsky G, Kriger A, Kalinin D, Mannelli L, Glotov A, Karelskaya N, Paklina O, Kaldarov A

  • Clin Radiol. 2017 Feb;72(2):150-158.

2017-01-13

Fig 1. The key role played by the thymus in T cell reconstitution after allo-HCT.

Fig 1. The key role played by the thymus in T cell reconstitution after allo-HCT.
  • Chaudhry MS, Velardi E, Malard F, van den Brink MR

  • J Immunol. 2017 Jan 1;198(1):40-46.

2017-01-16

Graphical Abstract

Graphical Abstract
  • Xu H, Valerio DG, Eisold ME, Sinha A, Koche RP, Hu W, Chen CW, Chu SH, Brien GL, Park CY, Hsieh JJ, Ernst P, Armstrong SA

  • Cancer Cell. 2016 Dec 12;30(6):863-878.

2017-01-17

Fig 3. Projection of the most important variables and interactions in the ePCR model.

Fig 3. Projection of the most important variables and interactions in the ePCR model.
  • Guinney J, Wang T, Laajala TD, Winner KK, Bare JC, Neto EC, Khan SA, Peddinti G, Airola A, Pahikkala T, Mirtti T

  • Lancet Oncol. 2017 Jan;18(1):132-142.

2017-01-18

Fig 1. CT scan reveals intrahepatic cholangiocarcinoma.

Fig 1. CT scan reveals intrahepatic cholangiocarcinoma.
  • Ierardi AM, Angileri SA, Patella F, Panella S, Lucchina N, Petre EN, Pinto A, Franceschelli G, Carrafiello G, Cornalba G, Sofocleous CT

  • Med Oncol. 2017 Jan;34(1):11.

2017-01-19

Fig 2. Evidence-based variant categorization.

Fig 2. Evidence-based variant categorization.
  • Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ, Younes A, Nikiforova MN

  • J Mol Diagn. 2017 Jan;19(1):4-23.

2017-01-20

Fig 2. Adrenocortical carcinoma, adrenal gland, ferret.

Fig 2. Adrenocortical carcinoma, adrenal gland, ferret.
  • Avallone G, Forlani A, Tecilla M, Riccardi E, Belluco S, Santagostino SF, Grilli G, Khadivi K, Roccabianca P

  • BMC Vet Res. 2016 Dec 5;12(1):275.
Open Access button

2017-01-23

Fig 1. Allo-HCT outcomes comparing 7/8 HLA high-resolution matched patients based on HLA-C encoded KIR ligand status (ie, C1, C2) and HLA match or mismatch.

Fig 1. Allo-HCT outcomes comparing 7/8 HLA high-resolution matched patients based on HLA-C encoded KIR ligand status (ie, C1, C2) and HLA match or mismatch.
  • Hoff GA, Fischer JC, Hsu K, Cooley S, Miller JS, Wang T, Haagenson M, Spellman S, Lee SJ, Uhrberg M, Venstrom JM

  • Biol Blood Marrow Transplant. 2017 Jan;23(1):153-160.

2017-01-24

Fig 2. Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomy.

Fig 2. Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomy.
  • Moghanaki D, Turkbey B, Vapiwala N, Ehdaie B, Frank SJ, McLaughlin PW, Harisinghani M

  • Semin Radiat Oncol. 2017 Jan;27(1):21-33.

2017-01-25

Fig 1. Percentage of patients with each grade 3-5 nonhematologic toxicity group.

Fig 1. Percentage of patients with each grade 3-5 nonhematologic toxicity group.
  • Scordo M, Bhatt V, Hsu M, Omuro AM, Matasar MJ, DeAngelis LM, Dahi PB, Moskowitz CH, Giralt SA, Sauter CS

  • Biol Blood Marrow Transplant. 2017 Jan;23(1):38-43.

2017-01-26

Fig 3. Causes of death in the entire population (A) and according to the HCT-CI (B).

Fig 3. Causes of death in the entire population (A) and according to the HCT-CI (B).
  • Barba P, Ratan R, Cho C, Ceberio I, Hilden P, Devlin SM, Maloy MA, Barker JN, Castro-Malaspina H, Jakubowski AA, Koehne G

  • Biol Blood Marrow Transplant. 2017 Jan;23(1):67-74.

2017-01-27

Fig 1. Radiomics analysis workflow. Radiomics-based analysis starts with segmentation of the structure(s) of interest, in this case, bladder cancer. Various texture features including Haralick textures are generated. A machine-learning classifier is trained using features generated from several images. Classification of various measures is then performed on never-seen-before images.

Fig 1. Radiomics analysis workflow. Radiomics-based analysis starts with segmentation of the structure(s) of interest, in this case, bladder cancer. Various texture features including Haralick textures are generated. A machine-learning classifier is trained using features generated from several images. Classification of various measures is then performed on never-seen-before images.
  • Sala E, Mema E, Himoto Y, Veeraraghavan H, Brenton JD, Snyder A, Weigelt B, Vargas HA

  • Clin Radiol. 2017 Jan;72(1):3-10.

2017-01-30

Fig 1. International Spine Radiosurgery Consortium anatomic classification system for consensus target volumes for spine radiosurgery (28).

Fig 1. International Spine Radiosurgery Consortium anatomic classification system for consensus target volumes for spine radiosurgery (28).
  • Redmond KJ, Robertson S, Lo SS, Soltys SG, Ryu S, McNutt T, Chao ST, Yamada Y, Ghia A, Chang EL, Sheehan J, Sahgal A

  • Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):64-74.

2017-01-31

Fig 2. Typical comprehensive whole-body magnetic resonance imaging protocol depicting extensive metastatic bone disease.

Fig 2. Typical comprehensive whole-body magnetic resonance imaging protocol depicting extensive metastatic bone disease.
  • Padhani AR, Lecouvet FE, Tunariu N, Koh DM, De Keyzer F, Collins DJ, Sala E, Schlemmer HP, Petralia G, Vargas HA, Fanti S

  • Eur Urol. 2017 Jan;71(1):81-92.

2017-02-01

Fig 4. Snapshot from Molecular Dynamics Simulation of γ-Secretase Complex with Inhibitor after 85 ns.

Fig 4. Snapshot from Molecular Dynamics Simulation of γ-Secretase Complex with Inhibitor after 85 ns.
  • Gertsik N, am Ende CW, Geoghegan KF, Nguyen C, Mukherjee P, Mente S, Seneviratne U, Johnson DS, Li YM

  • Cell Chem Biol. 2017 Jan 19;24(1):3-8.

2017-02-02

Fig 2. Heatmap summarizing the FDRs of 485 significant pathways and unsupervised hierarchical clustering of morphological features.

Fig 2. Heatmap summarizing the FDRs of 485 significant pathways and unsupervised hierarchical clustering of morphological features.
  • Heng YJ, Lester SC, Tse GM, Factor RE, Allison KH, Collins LC, Chen YY, Jensen KC, Johnson NB, Jeong JC, Punjabi R

  • J Pathol. 2017 Feb;241(3):375-391.

2017-02-03

Fig 4. In vivo quantitative evaluation of GW3965-loaded nanoparticles.

Fig 4. In vivo quantitative evaluation of GW3965-loaded nanoparticles.
  • Tang J, Baxter S, Menon A, Alaarg A, Sanchez-Gaytan BL, Fay F, Zhao Y, Ouimet M, Braza MS, Longo VA, Abdel-Atti D

  • Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6731-E6740.

2017-02-07

Fig 1. AhR negatively regulates CSR ex vivo.

Fig 1. AhR negatively regulates CSR ex vivo.
  • Vaidyanathan B, Chaudhry A, Yewdell WT, Angeletti D, Yen WF, Wheatley AK, Bradfield CA, McDermott AB, Yewdell JW, Rudensky AY, Chaudhuri J

  • J Exp Med. 2017 Jan;214(1):197-208.

2017-02-08

Fig 1. A cartoon depicting the four basic steps of the pretargeted.

Fig 1. A cartoon depicting the four basic steps of the pretargeted.
  • Houghton JL, Membreno R, Abdel-Atti D, Cunanan KM5, Carlin S, Scholz WW, Zanzonico PB, Lewis JS, Zeglis BM

  • Mol Cancer Ther. 2017 Jan;16(1):124-133.

2017-02-09

Fig 3. Anteroposterior (A) and lateral (B) postoperative radiographs demonstrating anterior and posterior instrumented fixation.

Fig 3. Anteroposterior (A) and lateral (B) postoperative radiographs demonstrating anterior and posterior instrumented fixation.
  • Lockney DT, Shub T, Hopkins B, Lockney NA, Moussazadeh N, Lis E, Yamada Y, Schmitt AM, Higginson DS, Laufer I, Bilsky M

  • Neurosurg Focus. 2017 Jan;42(1):E4.
Open Access button

2017-02-10

Fig 1. Flowchart of the prediction algorithm.

Fig 1. Flowchart of the prediction algorithm.
  • Zhang P, Rimner A, Yorke E, Hu YC, Kuo L, Apte A, Lockney N, Jackson A, Mageras G, Deasy JO

  • Phys Med Biol. 2017 Jan 10;62(3):702-714.

2017-02-13

Fig 1. Anterior and posterior (A/P) image count and associated automated BSI values in repeated bone scans of patients with same scanning speeds (Grp1) (A) and in repeated bone scans of patients with twice scanning speed of original scan (Grp2) (B).

Fig 1. Anterior and posterior (A/P) image count and associated automated BSI values in repeated bone scans of patients with same scanning speeds (Grp1) (A) and in repeated bone scans of patients with twice scanning speed of original scan (Grp2) (B).
  • Anand A, Morris MJ, Kaboteh R, Reza M, Trägårdh E, Matsunaga N, Edenbrandt L, Bjartell A, Larson SM, Minarik D

  • J Nucl Med. 2016 Dec;57(12):1865-1871.

2017-02-14

Fig 1. A similar 3′ flap DNA structure is generated during the L1 insertion process (TPRT) and the NER pathway.

Fig 1. A similar 3′ flap DNA structure is generated during the L1 insertion process (TPRT) and the NER pathway.
  • Servant G, Streva VA, Derbes RS, Wijetunge MI, Neeland M, White TB, Belancio VP, Roy-Engel AM, Deininger PL

  • Genetics. 2017 Jan;205(1):139-153.

2017-02-15

Fig 4. Correlation between mtDNA copy number and mtRNA expression.

Fig 4. Correlation between mtDNA copy number and mtRNA expression.
  • Reznik E, Wang Q, La K, Schultz N, Sander C

  • Elife. 2017 Jan 18;6. pii: e21592.
Open Access button

2017-02-16

Fig 2. Effects of the different Rep constructs on HSV-1 and AAV2 DNA replication.

Fig 2. Effects of the different Rep constructs on HSV-1 and AAV2 DNA replication.
  • Seyffert M, Glauser DL, Schraner EM, de Oliveira AP, Mansilla-Soto J, Vogt B, Büning H, Linden RM, Ackermann M, Fraefel C1

  • PLoS One. 2017 Jan 26;12(1):e0170908.
Open Access button

2017-02-17

Fig 3. Examples of mutational 3D clusters in tumor suppressor genes.

Fig 3. Examples of mutational 3D clusters in tumor suppressor genes.
  • Gao J, Chang MT, Johnsen HC, Gao SP, Sylvester BE, Sumer SO, Zhang H, Solit DB, Taylor BS, Schultz N, Sander C

  • Genome Med. 2017 Jan 23;9(1):4.
Open Access button

2017-02-20

Fig 3. FGFR1 overexpression attenuates the antiproliferative action of alpelisib.

Fig 3. FGFR1 overexpression attenuates the antiproliferative action of alpelisib.
  • Mayer IA, Abramson VG, Formisano L, Balko JM, Estrada MV, Sanders ME, Juric D, Solit D, Berger MF, Won HH, Li Y

  • Clin Cancer Res. 2017 Jan 1;23(1):26-34.

2017-02-21

Fig 1. Pathways and Current Drugs in Metastatic Renal-Cell Carcinoma.

Fig 1. Pathways and Current Drugs in Metastatic Renal-Cell Carcinoma.
  • Choueiri TK, Motzer RJ

  • N Engl J Med. 2017 Jan 26;376(4):354-366.

2017-02-22

Fig 1. Splicing catalysis, the spliceosome assembly pathway, and mechanisms of SS selection.

Fig 1. Splicing catalysis, the spliceosome assembly pathway, and mechanisms of SS selection.
  • Yoshimi A, Abdel-Wahab O

  • Clin Cancer Res. 2017 Jan 15;23(2):336-341.

2017-02-23

Fig 1. Genomic context and primary structure of Runella HD-Pnk.

Fig 1. Genomic context and primary structure of Runella HD-Pnk.
  • Munir A, Shuman S

  • J Bacteriol. 2016 Nov 28.

2017-02-24

Nat Commun. 2017 Jan 31;8:14248.

Nat Commun. 2017 Jan 31;8:14248.
  • Hoffmann TJ, Passarelli MN, Graff RE, Emami NC, Sakoda LC, Jorgenson E, Habel LA, Shan J, Ranatunga DK, Quesenberry CP, Chao CR

  • Fig 2. Results from a GWAS of PSA levels in 28,503 Kaiser Permanente non-Hispanic white non-cases.
Open Access button

2017-02-27

Fig 1. Signaling pathways in uveal melanoma.

Fig 1. Signaling pathways in uveal melanoma.
  • Krantz BA, Dave N, Komatsubara KM, Marr BP, Carvajal RD

  • Clin Ophthalmol. 2017 Jan 31;11:279-289.
Open Access button

2017-02-28

Fig 1. The estimated factor loadings onto the six factors after the Varimax rotation was performed.

Fig 1. The estimated factor loadings onto the six factors after the Varimax rotation was performed.
  • Steineck G, Skokic V, Sjöberg F, Bull C, Alevronta E, Dunberger G, Bergmark K, Wilderäng U, Oh JH, Deasy JO, Jörnsten R

  • PLoS One. 2017 Feb 3;12(2):e0171461.
Open Access button

2017-03-01

Fig 2. Circos plot showing called mutations in the ZMEL1 line.

Fig 2. Circos plot showing called mutations in the ZMEL1 line.
  • Kansler ER, Verma A, Langdon EM, Simon-Vermot T, Yin A, Lee W, Attiyeh M, Elemento O, White RM

  • BMC Genomics. 2017 Feb 7;18(1):136.
Open Access button

2017-03-02

Fig 1. Melanomas become differentiated after dissemination to secondary sites.

Fig 1. Melanomas become differentiated after dissemination to secondary sites.
  • Kim IS, Heilmann S, Kansler ER, Zhang Y, Zimmer M, Ratnakumar K, Bowman RL, Simon-Vermot T, Fennell M, Garippa R, Lu L

  • Nat Commun. 2017 Feb 9;8:14343.
Open Access button

2017-03-06

Fig 7. Model for putative PS-induced enhancement of ACD11.

Fig 7. Model for putative PS-induced enhancement of ACD11.
  • Zhai X, Gao YG, Mishra SK, Simanshu DK, Boldyrev IA, Benson LM, Bergen HR, Malinina L, Mundy J, Molotkovsky JG, Patel DJ

  • J Biol Chem. 2017 Feb 10;292(6):2531-2541.

2017-03-07

Fig 3. Topical tacrolimus decreases fibrosis in lymphedema.

Fig 3. Topical tacrolimus decreases fibrosis in lymphedema.
  • Gardenier JC, Kataru RP, Hespe GE, Savetsky IL, Torrisi JS, Nores GD, Jowhar DK, Nitti MD, Schofield RC, Carlow DC, Mehrara BJ

  • Nat Commun. 2017 Feb 10;8:14345.
Open Access button

2017-03-08

Fig 1. ATM and ATR are activated by DNA damage as well as DNA replication stress.

Fig 1. ATM and ATR are activated by DNA damage as well as DNA replication stress.
  • Carlucci G, Carney B, Sadique A, Vansteene A, Tang J, Reiner T

  • Nucl Med Biol. 2017 Jan 16;48:9-15.

2017-03-09

Fig 5. Systemic toxicity profiles of FiBYL719 nanoparticles.

Fig 5. Systemic toxicity profiles of FiBYL719 nanoparticles.
  • Mizrachi A, Shamay Y, Shah J, Brook S, Soong J, Rajasekhar VK, Humm JL, Healey JH, Powell SN, Baselga J, Heller DA

  • Nat Commun. 2017 Feb 13;8:14292.
Open Access button

2017-03-10

Fig 2. Schematic illustrations of nanomaterials platforms, which are approved, in preclinical development, or in clinical trials.

Fig 2. Schematic illustrations of nanomaterials platforms, which are approved, in preclinical development, or in clinical trials.
  • Scheinberg DA, Grimm J, Heller DA, Stater EP, Bradbury M, McDevitt MR

  • Current Opinion in Biotechnology. 2017 Aug;46:66-73.

2017-03-13

Fig 2. Multimodal imaging of Case 2 showing bilateral choroidal infiltration with associated serous retinal detachment (SRD) owing to Erdheim-Chester disease and the response to systemic treatment with the subsequent development of a secondary choroidal neovascularization.

Fig 2. Multimodal imaging of Case 2 showing bilateral choroidal infiltration with associated serous retinal detachment (SRD) owing to Erdheim-Chester disease and the response to systemic treatment with the subsequent development of a secondary choroidal neovascularization.
  • Tan AC, Yzer S, Atebara N, Marr BP, Verdijk RM, Dalm VA, Freund KB, Yannuzzi L, Missotten T

  • Am J Ophthalmol. 2017 Apr;176:141-7.

2017-03-14

Fig 1. Kaplan–Meier analysis of associations of the CD8 EM1 (A) and EMRA (B) T-cell compartments with OS at baseline (n = 137 for both analyses).

Fig 1. Kaplan–Meier analysis of associations of the CD8 EM1 (A) and EMRA (B) T-cell compartments with OS at baseline (n = 137 for both analyses).
  • Wistuba-Hamprecht K, Martens A, Heubach F, Romano E, Foppen MG, Yuan J, Postow M, Wong P, Mallardo D, Schilling B, Di Giacomo AM

  • Eur J Cancer. 2017 Mar;73:61-70.

2017-03-15

Fig 5. Somatic aberrations in the PI3K pathway dysregulate cancer-specific TFs.

Fig 5. Somatic aberrations in the PI3K pathway dysregulate cancer-specific TFs.
  • Osmanbeyoglu HU, Toska E, Chan C, Baselga J, Leslie CS

  • Nat Commun. 2017 Jan 31;8:14249.
Open Access button

2017-03-16

Fig 4. Concurrent somatic alterations in validation data set.

Fig 4. Concurrent somatic alterations in validation data set.
  • Ross DS, Zehir A, Cheng DT, Benayed R, Nafa K, Hechtman JF, Janjigian YY, Weigelt B, Razavi P, Hyman DM, Baselga J, Berger MF, Ladanyi M, Arcila ME

  • J Mol Diagn. 2017 Mar;19(2):244-254.

2017-03-20

Fig 1. The RAS/MAPK pathway and RASopathies.

Fig 1. The RAS/MAPK pathway and RASopathies.
  • Kiuru M, Busam KJ

  • Lab Invest. 2017 Feb;97(2):146-157.

2017-03-21

Fig 1. Different bispecific antibody formats.

Fig 1. Different bispecific antibody formats.
  • Hoseini SS, Cheung NK

  • Blood Cancer J. 2017 Feb 3;7(2):e522.
Open Access button

2017-03-22

Fig 4. Incomplete and individualized recovery of the human microbiota after vancomycin withdrawal.

Fig 4. Incomplete and individualized recovery of the human microbiota after vancomycin withdrawal.
  • Isaac S, Scher JU, Djukovic A, Jiménez N, Littman DR, Abramson SB, Pamer EG, Ubeda C

  • J Antimicrob Chemother. 2017 Jan;72(1):128-136.
Open Access button

2017-03-23

Fig 1. Participant flow diagram.

Fig 1. Participant flow diagram.
  • Friese CR, Mendelsohn-Victor K, Ginex P, McMahon CM, Fauer AJ, McCullagh MC

  • J Nurs Scholarsh. 2017 Mar;49(2):194-201.

2017-03-24

Fig 2. TRAC-CAR T cells display reduced constitutive signalling and antigen-induced differentiation.

Fig 2. TRAC-CAR T cells display reduced constitutive signalling and antigen-induced differentiation.
  • Eyquem J, Mansilla-Soto J, Giavridis T, van der Stegen SJ, Hamieh M, Cunanan KM, Odak A, Gönen M, Sadelain M

  • Nature. 2017 Mar 2;543(7643):113-117.

2017-03-27

The map of the integrative vector pIMBT1 suitable for the genus Amycolatopsis.

The map of the integrative vector pIMBT1 suitable for the genus Amycolatopsis.
  • Lei X, Zhang C, Jiang Z, Li X, Shi Y, Liu M, Xie Y, Wang L, Hong B

  • J Biotechnol. 2017 Feb 16;247:6-10.

2017-03-28

Fig 1. Pathology images.

Fig 1. Pathology images.
  • Di Franco A, Gaudino M, Weinsaft JW, Pun SC, Narula N, Khan SA, Malik ZM, Ohmes LB, Skubas NJ, Girardi LN

  • Ann Thorac Surg. 2017 Feb;103(2):e131-e133.

2017-03-29

Fig 4. Atomistic MD simulations of the TMD of ADAM17 and Rhbdf2 TMD1.

Fig 4. Atomistic MD simulations of the TMD of ADAM17 and Rhbdf2 TMD1.
  • Li X, Maretzky T, Perez-Aguilar JM, Monette S, Weskamp G, Le Gall S, Beutler B, Weinstein H, Blobel CP

  • J Cell Sci. 2017 Mar 1;130(5):868-878.

2017-03-30

Fig 2. RECIST 1.1 and iRECIST: an example of assessment.

Fig 2. RECIST 1.1 and iRECIST: an example of assessment.
  • Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S, Lin NU, Litière S, Dancey J, Chen A, Hodi FS

  • Lancet Oncol. 2017 Mar;18(3):e143-e152.

2017-03-31

Conventional transbronchial forceps biopsy specimens (A) are smaller and usually show more procedural artifacts than transbronchial cryobiopsy specimens (B)

Conventional transbronchial forceps biopsy specimens (A) are smaller and usually show more procedural artifacts than transbronchial cryobiopsy specimens (B)
  • Roden AC, Aisner DL, Allen TC, Aubry MC, Barrios RJ, Beasley MB, Cagle PT, Capelozzi VL, Dacic S, Ge Y, Hariri LP, Lantuejoul S, Miller RA, Mino-Kenudson M, Moreira AL, Raparia K, Rekhtman N, Sholl L, Smith ML, Tsao MS, Vivero M, Yatabe Y, Yi ES

  • Arch Pathol Lab Med. 2017 Mar;141(3):437-444.
Open Access button